A team of scientists formerly working at Google DeepMind and Owkin have joined forces to create Bioptimus, a start-up that will apply generative artificial intelligence (GenAI) to the discovery, development, and use of personalised medicines.The new company, based in Paris, France, starts life with $35 million in funding from a consortium led by Sofinnova Partners […]
